MedPAC to CMS: Shift more products into bid program

Wednesday, November 22, 2017

WASHINGTON – The Medicare Payment Advisory Committee made payment policy recommendations for non-competitively bid DMEPOS during a meeting earlier this month, according to Epstein Becker & Green, a healthcare law firm. MedPAC plans to recommend that CMS shift more products away from the “excessive” fee schedule to bid rates. It also plans to call for “immediate reduced payment rates for certain non-CBP products while CMS works on incorporating them into the CBP,” the law firm reports in a post for The National Review. Alternatively, MedPAC plans to recommend a policy option that would have CMS consider capping balance billing at a percentage of the fee schedule rate and reduce the allowed amount by 5% for non-participating providers, the law firm reported.